Total synthesis of (-)-CP2-disorazole C1

Organic Letters

Volumn 13, Issue 15, 2011, Pages 4088-4091

  Hopkins, Chad D ^a   Schmitz, John C ^b,c   Chu, Edward ^c,d   Wipf, Peter ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Molecular Therapeutics Drug Discovery Program   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CP2 DISORAZOLE C1; CP2-DISORAZOLE C1; DISORAZOLE C1; ETHER; MACROLIDE; OXAZOLE DERIVATIVE;

ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; ETHER, ETHYL; HUMANS; MACROLIDES; MOLECULAR STRUCTURE; OXAZOLES;

EID: 79961051536     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol2015994     Document Type: Article

References (42)

1. Jansen, R.; Irschik, H.; Reichenbach, H.; Wray, V.; Höfle, G. Liebigs Ann. Chem. 1994, 759
2. For reviews of disorazole chemistry and biology, see: Hopkins, C. D.; Wipf, P. Nat. Prod. Rep. 2009, 26, 585
3. Weissman, K. J.; Mueller, R. Nat. Prod. Rep. 2010, 27, 1276
4. Kretschmer, M.; Menche, D. Synlett 2010, 2989
5. Wipf, P.; Graham, T. H.; Xiao, J. Pure Appl. Chem. 2007, 79, 753
6. Lazo, J. S.; Reese, C. E.; Vogt, A.; Vollmer, L. L.; Kitchens, C. A.; Günther, E.; Graham, T. H.; Hopkins, C. D.; Wipf, P. J. Pharmacol. Exp. Ther. 2010, 332, 906
7. Xu, F. L.; Rbaibi, Y.; Kiselyov, K.; Lazo, J. S.; Wipf, P.; Saunders, W. S. BMC Chem. Biol. 2010, 10, 1
8. Tierno, M. B.; Kitchens, C. A.; Petrik, B.; Graham, T. H.; Wipf, P.; Xu, F. L.; Saunders, W. S.; Raccor, B. S.; Balachandran, R.; Day, B. W.; Stout, J. R.; Walczak, C. E.; Ducruet, A. P.; Reese, C. E.; Lazo, J. S. J. Pharm. Exp. Ther. 2009, 328, 715
9. Wipf, P.; Graham, T. H.; Vogt, A.; Sikorski, R. P.; Ducruet, A. P.; Lazo, J. S. Chem. Biol. Drug Des. 2006, 67, 66
10. Hearn, B. R.; Arslanian, R. L.; Fu, H.; Liu, F.; Gramajo, H.; Myles, D. C. J. Nat. Prod. 2006, 69, 148
11. Elnakady, Y. A.; Sasse, F.; Lünsdorf, H.; Reichenbach, H. Biochem. Pharmacol. 2004, 67, 927
12. Wipf, P.; Graham, T. H. J. Am. Chem. Soc. 2004, 126, 15346
13. Schaeckel, R.; Hinkelmann, B.; Sasse, F.; Kalesse, M. Angew. Chem., Int. Ed. 2010, 49, 1619
14. Niess, B.; Hartung, I. V.; Haustedt, L. O.; Hoffmann, H. M. R. Eur. J. Org. Chem. 2006, 1132
15. Hearn, B. R.; Arslanian, R. L.; Fu, H.; Liu, F.; Gramajo, H.; Myles, D. C. J. Nat. Prod. 2006, 69, 148
16. Haustedt, L. O.; Panicker, S. B.; Kleinert, M.; Hartung, I. V.; Eggert, U.; Niess, B.; Hoffmann, H. M. R. Tetrahedron 2003, 59, 6967
17. Hartung, I. V.; Eggert, U.; Haustedt, L. O.; Niess, B.; Schaefer, P. M.; Hoffmann, H. M. R. Synthesis 2003, 1844
18. Hartung, I. V.; Niess, B.; Haustedt, L. O.; Hoffmann, H. M. R. Org. Lett. 2002, 4, 3239
19. Hillier, M. C.; Price, A. T.; Meyers, A. I. J. Org. Chem. 2001, 66, 6037
20. Wang, Z.; McPherson, P. A.; Raccor, B. S.; Balachandran, R.; Zhu, G.; Day, B. W.; Vogt, A.; Wipf, P. Chem. Biol. Drug Des. 2007, 70, 75
21. Powis, G.; Wipf, P.; Lynch, S. M.; Birmingham, A.; Kirkpatrick, D. L. Mol. Cancer Ther. 2006, 5, 630
22. Wipf, P.; Minion, D. J.; Halter, R. J.; Berggren, M. I.; Ho, C. B.; Chiang, G. G.; Kirkpatrick, L.; Abraham, R.; Powis, G. Org. Biomol. Chem. 2004, 2, 1911
23. Wipf, P.; Fritch, P. C.; Geib, S. J.; Sefler, A. M. J. Am. Chem. Soc. 1998, 120, 4105
24. Examples documenting the lability of trienes include: Burke, C. P.; Haq, N.; Boger, D. L. J. Am. Chem. Soc. 2010, 132, 2157
25. Hicks, J. D.; Roush, W. R. Org. Lett. 2008, 10, 681
26. Trost, B. M.; Frederiksen, M. U.; Papillon, J. P. N.; Harrington, P. E.; Shin, S.; Shireman, B. T. J. Am. Chem. Soc. 2005, 127, 3666
27. Fuwa, H.; Sasaki, M.; Satake, M.; Tachibana, K. Org. Lett. 2002, 4, 2981
28. Nicola, T.; Brenner, M.; Donsbach, K.; Kreye, P. Org. Process Res. Dev. 2005, 9, 513
29. Salit, A.-F.; Meyer, C.; Cossy, J.; Delouvrié, B.; Hennequin, L. Tetrahedron 2008, 64, 6684
30. Salit, A.-F.; Meyer, C.; Cossy, J. Synlett 2007, 934
31. Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18
32. 3SnOH, led to significant β-elimination at C6.
33. Phillips, A. J.; Uto, Y.; Wipf, P.; Reno, M. J.; Williams, D. R. Org. Lett. 2000, 2, 1165
34. Kiyooka, S.; Kaneko, Y.; Komura, M.; Matsuo, H.; Nakano, M. J. Org. Chem. 1991, 56, 2276
35. Lu, Z.; Ma, S. Angew. Chem., Int. Ed. 2008, 47, 258
36. Hafner, A.; Duthaler, R. O.; Marti, R.; Rihs, G.; Rothe-Streit, P.; Schwarzenbach, F. J. Am. Chem. Soc. 1992, 114, 2321
37. Cossy, J.; Willis, C.; Bellosta, V.; BouzBouz, S. J. Org. Chem. 2002, 67, 1982
38. Jarosz, S.; Gajewska, A.; Luboradzki, R. Tetrahedron: Asymmetry 2008, 19, 1385
39. Shiina, I.; Kubota, M.; Oshiumi, H.; Hashizume, M. J. Org. Chem. 2004, 69, 1822
40. Schweitzer, D.; Kane, J. J.; Strand, D.; McHenry, P.; Tenniswood, M.; Helquist, P. Org. Lett. 2007, 9, 4619
41. For cyclopropane analogs of natural products, see: Cachoux, F.; Isarno, T.; Wartmann, M.; Altmann, K.-H. Synlett 2006, 1384
42. Wipf, P.; Reeves, J. T.; Balachandran, R.; Day, B. W. J. Med. Chem. 2002, 45, 1901